Istituto Oncologico della Svizzera Italiana (IOSI)

Bellinzona 6500

1 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Early Breast Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Relapsed/Refractory Burkitt Lymphoma, Relapsed/Refractory Hairy Cell Leukemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Waldenstrom Macroglobulinemia, Solid and Hematological Malignancies

Studies at this site

• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells — Enrolling by invitation
• Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies — Stopped early
• Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer — Running, not enrolling
• Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors — Completed